HIV Diagnostics Market: By Test (Antibody Tests, Viral Identification, CD4 Testing, Viral Load Testing, Others), By End-User (Hospitals, Diagnostic Centers, Blood Banks, Home Care Settings), And Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

HIV Diagnostics Market size was valued at USD 3.3 billion in 2022 and is poised to grow at a CAGR of 9.8% from 2023-2029. Acquired immune deficiency syndrome (AIDS) is a retroviral infectious disease caused by human immunodeficiency virus (HIV). HIV attacks the body immune system ideally CD4 cells (T cells), which helps the immune system to fight infections. HIV spreads through body fluids i.e. blood donation and imparting needles to somebody who is HIV infected, and sexual interactions. If HIV is not treated the opportunistic infections like tuberculosis or cancer take advantage of very weak immune system and causes AIDS. The HIV Diagnostics Market can be done by viral load test, saliva test, and blood test. Most accurate test results can obtained by enzyme linked immunosorbent assay (ELISA) test initial stages and western blot method on later stages. Currently, there was no effective cure exists for HIV, but with proper medical care, it can be controlled. Global HIV diagnosis market is growing at steady state. Government and non-government organizations are also participating in creating and growing awareness related to early HIV diagnosis and available diagnostic tests and equipment. According to WHO, 2015, there is 0.8% prevalence of HIV globally and Sab-Saharan Africa remains most severely affected area with 70% of people for global population. For instance, the unmet requirements in Asia and Africa region for HIV diagnosis, and the government initiatives taken in the region may drive the market for HIV diagnostics. Market players adopting mergers and acquisitions to increase the market position in HIV diagnostics market. In addition, market has a number of pipeline products in accurate and quick diagnosis of HIV few of them are Visitect CD4, Chipcare CD4, and MBIO CD4. Antibody diagnosis test is predominant among the segments. Due to the introduction of point of care products can easily and quickly diagnose disease.

Global Hiv Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
HIV Diagnostics Market Dynamics

HIV diagnostics market is driven by global increase in prevalence of HIV/AIDS, rise in number of blood transfusions and blood donations, benefits of point-of-care instruments & kits in which patients can be diagnosed even outside the laboratory setting, and increasing government initiatives. In addition, technological advancements in disease diagnostic tests, improvement and commercialization of novel, regulatory approved point of care and rapid CD4, p24 antigen and EID tests are expected to boost the HIV diagnostics market over the forecast period. However, lack of awareness in many undeveloped regions, stringent government regulations and unfavourable reimbursement policies would limit the growth of the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Hiv Diagnostics Market Segmentation

By Type of Test
  • CD4 Count
  • Antibody Test
  • Viral Identification
  • Viral Load
  • Others
By End User
  • Hospitals
  • Diagnostic Centers
  • Blood Banks
  • Home Care Settings
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

the HIV Diagnostics Market size was valued at USD 3.3 billion in 2022, with a CAGR of 9.8% during the review period 2023-2029.

F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Siemens Healthineers) (Germany), Merck KGaA (Germany), Hologic, Inc. (U.S.)

Asia-Pacific is the fastest-growing region for HIV diagnostics market

    1. Executive summary
    2. Global HIV Diagnostics Market Introduction
      • Global HIV Diagnostics Market- Taxonomy
      • Global HIV Diagnostics Market-Definitions
        • End User
        • Test Type
    1. Global HIV Diagnostics Market Dynamics
      • Drivers
      • Restraints
      • Opportunities/Unmet Needs of the Market
      • Trends
      • Global HIV Diagnostics Market Dynamics - Factors Impact Analysis
      • Global HIV Diagnostics Market- Recent Product Launches
    2. Global HIV Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Market Oppurtunity Analysis
    3. Global HIV Diagnostics Market Forecast, By Test Type, 2018 - 2022 and Forecast, 2023 - 2029
      • CD4 Count
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Antibody Test
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Viral Identification
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Viral Load
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global HIV Diagnostics Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
      • Hospitals
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Diagnostic Centers
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Blood Banks
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Home Care Settings
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global HIV Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
      • North America
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Europe
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Asia-Pacific
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Latin America
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Middle East and Africa
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Global HIV Diagnostics Market- Opportunity Analysis Index - By Test Type, By End User, and Region, 2023 - 2029
    2. North America HIV Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      • Test Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • CD4 Count
        • Antibody Test
        • Viral Identification
        • Viral Load
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Blood Banks
        • Home Care Settings
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • S.
        • Canada
      • North America HIV Diagnostics Market- Opportunity Analysis Index - By Test Type, By End User, and Country, 2023 - 2029
      • North America HIV Diagnostics Market Dynamics - Trends
    3. Europe HIV Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      • Test Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • CD4 Count
        • Antibody Test
        • Viral Identification
        • Viral Load
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Blood Banks
        • Home Care Settings
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe HIV Diagnostics Market- Opportunity Analysis Index - By Test Type, By Application, By End User, and Country, 2023 - 2029
      • Europe HIV Diagnostics Market Dynamics - Trends
    4. Asia-Pacific HIV Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      • Test Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • CD4 Count
        • Antibody Test
        • Viral Identification
        • Viral Load
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Blood Banks
        • Home Care Settings
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn),
    5. Y-o-Y Growth (%), and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific HIV Diagnostics Market- Opportunity Analysis Index - By Test Type, By End User, and Country, 2023 - 2029
    • Asia-Pacific HIV Diagnostics Market Dynamics - Trends
    1. Latin America HIV Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      • Test Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • CD4 Count
        • Antibody Test
        • Viral Identification
        • Viral Load
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Blood Banks
        • Home Care Settings
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America HIV Diagnostics Market- Opportunity Analysis Index - By Test Type, End User, and Country, 2023 - 2029
      • Latin America HIV Diagnostics Market Dynamics - Trends
    2. Middle East & Africa HIV Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      • Test Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • CD4 Count
        • Antibody Test
        • Viral Identification
        • Viral Load
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Blood Banks
        • Home Care Settings
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA HIV Diagnostics Market- Opportunity Analysis Index - By Test Type, By End User, and Country, 2023 - 2029
      • MEA HIV Diagnostics Market Dynamics - Trends
    3. Competition Landscape
      • Strategic Dashboard of Top Market Players
      • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
        • Hoffmann-La Roche AG (Switzerland)
        • Abbott Laboratories (U.S.)
        • Siemens AG (Siemens Healthineers) (Germany)
        • Hologic, Inc. (U.S.)
        • Fisher Bioblock Holding II SNC (Thermo-Fisher Scientific) (U.S.)
        • Becton, Dickinson and Company (U.S.)
        • Alere Inc. (U.S.)
        • Bio-Rad Laboratories (U.S.)
    4. Research Methodology
    5. Key Assumptions and Acronyms
  • F. Hoffmann-La Roche AG (Switzerland)
  • Abbott Laboratories (U.S.)
  • Siemens AG (Siemens Healthineers) (Germany)
  • Merck KGaA (Germany)
  • Hologic, Inc. (U.S.)
  • Thermo-Fisher Scientific (Fisher Bioblock Holding II SNC) (U.S.)
  • Becton, Dickinson and Company (U.S.),Alere Inc. (U.S.)
  • Bio-Rad Laboratories (U.S.)

Adjacent Markets